REFERENCES
- Elewski BE, Elgart ML, Jacobs PH, Lesher JL, Scher RK. Guidelines of care for superficial mycotic infections of the skin: onychomycosis. J Amer Acad Derm 1996; 34: 116–121.
- Seebacher C, Brasch J, Abeck D, et al. Onychomycosis. Mycoses 2007; 50: 321–7.
- Aranjo MG, Bastos OMP, Souza MM, Oliveira JC. Ony-chomycosis caused by emergent fungi: clinical analysis, diagno-sis and revision. An Bras Dermatol 2003; 78: 445–455.
- Gupta AK, Ryder JE, Summerbell RC. Onychomycosis: classification and diagnosis. J Drugs Dermatol 2004; 3: 51–56.
- Haneke E. Fungal infections of the nail. Semin Dermatol 1991; 10: 41–53.
- Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol 2000; 42: 217–224.
- Melody R, Vander S, Maher MB, Mahmoud AG. The role of nondermatophyte molds in onychomycosis: diagnosis and treatment. Dermatologic Therapy 2002; 15: 89–98.
- Denning DW, Evans EGV, Kibbler CC, Richardson MD, Roberts MM, Rogers TR, et al. Fungal nail diseases: a guide to good practice (report of a working group of the British society for medical mycology). Br Med J 1995; 311: 1277–81.
- Veer P, Patwardhan NS, Damle AS. Study of onycomyco-sis: prevailing fungi and pattern of infection. Indian J Med Mi-crobiol 2007; 25: 53–6.
- Roberts DT, Taylor WD, Boyle J. Guidelines for treatment of onychomycosis. Br J Dermatol 2003; 148: 402–410.
- Gupta AK, Ryder JE, Johnson AM. Cumulative meta-analysis of systemic antifungal agents for the treatment of ony-chomycosis. Br J Dermatol 2004; 150: 537–544.
- Baran R, Kaoukhov A. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Derma-tol Venereol 2005; 19: 21–29.
- Seebacher C, Nietsch KH, Ulbricht HM. A multicenter, open label study of the efficacy and safety of cicloprox nail lac-quer solution 8% for the treatment of onychomycosis in patients with diabetes. Cutis 2001; 68 (2): 17–22.
- Gupta AK. Onychomycosis in the elderly. Drugs Aging 2000; 16: 397–407.
- Marty JPL. Amorolfine nail lacquer: a novel formulation. J Eur Acad Dermatol Venereol 1995; 4 (1): 17–21.
- NoRing S, Brautigam M, Weidinger G. Terbinafine in ony-chomycosis with involvement by non-dermatophytic fungi. Br J Dermatol 1994;13 (43): 16–21.
- de Hoog GS, Guarro J, Gene' J, Figueras MJ, eds. Hy-phomycetes: explanatory chapters, and keys to the genera. In: Atlas of Clinical Fungi, 2th ed. Baam: Centraalbureau vor Schim-melcultures. 2000: 361.
- Clinical and Laboratory Standards Institute/National Com-mittee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of fila-mentous fungi. Approved standards. NCCLS document M38-A. National Committee for Clinical Laboratory Standards. Wayne, Pa.
- NCCLS/CLSI. 2002. Reference method for broth dilution susceptibility testing of yeast. Approved standard, 2nd ed. M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
- Ellis DH. Diagnosis of onychomycosis made simple. J Am Acad Dermatol 1990; 40: 3–8.
- Borkowski P, Williams M, Holewinski J, et al. Ony-chomycosis: an analysis of 50 cases and a comparison of diag-nostic techniques. J Am Podiatr Med Assoc 2002; 91: 351–5.
- Artis WM, Odle BM, Jones HE. Griseofulvin-resistant der-matophytosis correlates with in vitro resistance. Arch Dermatol 1981; 117: 16–19.
- Piérard GE, Piérard-Franchimont C, Arrese JE. The boosted antifungal topical treatment (BATT) for onycomycosis. Med Mycol 2000; 38: 391–392.
- Gianni C, Romano C. Clinical and histological aspects of toenail onychomycosis caused by Aspergillus spp.: 34 cases treated with weekly intermittent terbinafine. Dermatology 2004; 209 (2): 104-10.